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In bc complexes, cytochcome 6 plays a major role in electron transfer and in proton tcanslocation accross the membrane. Several inhibitor-resistant 
and respiratory-deficient mutants have already been used to study the structure-function relationships of this integral membrane protein. We de- 
scribe here the selection and the molecular analysis of revertants from a thetmo-sensitive mit-mutant of known nucleotide changes, Among 80 
independent pseudo-wild type revertants creened by DNA-labelled oligonucleotide hybridization, 33 have been sequenced. Eight suppressor muta- 
tions, affecting a region critical for both the. function and the binding of center o inhibitors (end of helix C) were identified. Two of them were 
found to be more resistant o myxothiazol. 
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1. INTRODUCTION 
Cytochrome bc complexes catalyze the electron 
transfer from ubiquinol to cytochrome c or plasto- 
cyanine in association with a vectorial proton transloca- 
tion. Although they differ in their protein composition, 
all the bc complexes contain the same redox proteins 
[l], i.e. cytochrome b, cytochrome cl and iron-sulfur 
protein, which seem to be the only polypeptides in- 
volved in oxidoreduction reaction [2,3]. In eucaryotes, 
all the subunits are nuclearly inherited, except 
cytochrome b which is encoded by the mitochondrial 
DNA [4]. Cytochrome b is an integral membrane pro- 
tein carrying two haems, bH and bL, presumably 
asymetrically disposed toward the inner and outer sides 
of the membrane, respectively [5-71. The two haems are 
supposed to form a transmembrane lectron circuit be- 
tween two ubiquinone redox sites Qi and Q0 according 
to the Q cycle scheme IS]. 
The structure of such a membrane complex protein is 
very difficult to investigate, so the use of cytochrome b 
mutants provide a ,good tool to study the structure- 
function relationships of this prbtein. Two kinds of 
cytochfome b mutants carryLg missense mutations in 
the cytochrome b gene have been studied: (i) mutants 
exhibiting a resistance to proton-motive Q cycle in- 
hibitors which interact with the bcl; DNA sequence 
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analysis of numerous mutants from several species 
f9-163 has shown that inhibitor resistance was confer- 
red by specific amino acid replacements in discrete 
regions of the protein. (ii) Mutants unable to grow on 
respiratory substrates previously mapped in the 
cytochrome b gene, carrying single amino acid substitu- 
tions which impair bcl complex assembly [17,18] or af- 
feet’ directly the electron transfer chain [17,19,20]. 
More recently, new mutants have been selected as rever- 
tants from respiratory-deficient mutants [21,22]. The 
analysis of such mutants has revealed interesting 
features for the understanding of cytochrome b func- 
tion and is very useful in the study of the three- 
dimensional structure of this protein. In the present 
work, we describe the selection and the molecular 
analysis of revertants selected from a thermo-sensitive 
mutant previously selected as a revertant of a respira- 
tory-deficient mutant 12219 GS012 (c-133” >Y), 
specifically affected at the haem bt level [7]. About 80 
independent revertants obtained at non permissive 
temperature (37’C) were screened by oligonucleotide 
hybridization as described in [21]. Eight different sup- 
pressor mutations responsible for the restoration of 
growth at 37“C were identified by sequencing the 
cytochrome b mRNA in crude mitochondrial RNA 
preparations from 33 independent revereants. The 
results will be discussed comparatively to other data 
from several inhibitor-resistant and respiratory- 
deficient miitants found in,the same region of the pro- 
tein. a region that seems to be critical for the quinol ox- 
idation and the binding of center o inhibitors. 
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2. MATERIALS AND METHODS decreased to 30°C and hybridization continued overnight. Filters 
were progressively washed in 6 x SSC at selected temperatures and 
2.1. Media autoradiographed after each washing. 
YP 10: 10% glucose, 1% yeast extract, 1% bactopeptone; YPG: 
2% glucose, 1 Q7o yeast extract, lvo bactopeptone; YPGAL: 2% galac- 2.5. RNA sequencing 
tose, 1% yeast extract, 1% bactopeptone; N3: 2% glycerol, 1% yeast Cytochrome b mRNA from crude RNA preparations was sequenc- 
extract, 1% bactopeptone:Solid media contained 2% agar. ed by primer extension with AMV reverse transcriptase as described 
2.2. Strains 
in [13-15,241. 
KM91 (wt), 777-3A, (Y ade opl x KL14-4A, a his1 frp I (from the 2.6. Grow/h rate measurements 
Gif collection). The ts rho’ mit’ cytochrome B mutant JDG3012/117 Growth on glycerol was performed at 28’C and moniiored with a 
[22] was isolated from the diploid strain KM710: 777-3A/G3012, (Y Klett densitometer. Generation time was determined from the ex- 
adeopl mir x KLl4-4A/Sl, a his1 lrpl rho’. The original mit- muta- ponential growth phase. 
tion (G3012) was localized by deletion mapping at the end of exon I 
of the split cytochrome b gene [23] and its mitDNA sequence deter- 2.7. In vivo tnyxothiazol tolerance test 
mined (c~>Y)[7]. The revertants were checked for their ability to grow on glycerol 
2.3 I Isolation of the respiratory competent revertants 
plates in the presence of increased concentrations of myxothiazol 
ranging from 0.1-l p&ml. 
Respiratory competent revertants were selected on N3 medium 
from the diploid mutant strain JDG3012/117 as described in [21] ex- 
cept that the selection was carried out at 37OC (non-permissive 
temberature) instead of 28OC. 
3. RESULTS 
The rho+ 
2.4. Oligonucieotide hybridization 
mit’ ts mutant JDG3012/1l7 has been 
DNAextracted from revertants as described in [al] were loaded on 
selected as revertant [22] from the respiratory-deficient 
nylon filters (Amersham), soaked twice for 3 min in 0.5 M NaOH, 1.5 mutant C3012 (C.133->Y) which has previously been 
M NaCI, 0.1% SDS then twice for 3 min in 0.S M Tris-Cl, pH 7.5, 1.5 described as being specifically affected at the haem by 
M NaCI. Filters were dried and exposed for 4 min to UV (305 nm) in level [7]. The strain JDG3012/117 exhibited a weak 
order to fix the DNA on the filters, then prehybridized for 30 min at 
room temperature in 30 ml of mixed 10 x Denhardt, 6 x SSC (Stand- 
growth on glycerol at 28°C’ and did not grow on 
ard Sodium Citrate). The temperature was increased to 80°C and 10 
glycerol at 37’C. The sequence analysis of this ‘thermo- 
pmol of a 32P end labelled oligonucleotide covering the initial muta- sensitive revertant’ has revealed that the suppressor 
tion of JDG3012/117 were added. The temperature was gradually mutation led to the replacement of alanine 126 by a 
Table I 
mt DNA sequence alterations of revertants from the thermo-sensitive mit- mutant JDG3012/117 
Type Tm 
OC 
126 ITCI 133 135 138 
Residues IATAFLGYCCVYGQ 
Wt sequence ATT.GCT.A~A.G~T.TTT.TTA.GCT.PAT.TAT.TGT.TGT.GTT.T~T.G~A.~AG 
Oligonucleotide "TCCAATAACAACACAAATACGTGTC" 64 
JEIG30'l2/11? T Y 
ACT TAT 54 
II R5 (5) T S 
ACT TCT 54 
w3 (7) T F 
ACT TTY 55 
RIB (2) T N 
ACT AAT 53 
823 (1) T D 
ACT GAP 54 
a110 (I) T H 
ACT CAT 53 
I RI1 (3) T C 
ACT TGT 64 
II RS7 (4) T Y I 
ACT TAT ATT 50 
III R82 (I) T n Y 
ACT ATA TAT 56 
The mt DNA sequence of JDG3012/117 was determined by Di Rapo et al. [22]. Revertants (R, followed by a number) were screened by labelled 
oligonucleotide hybridization as described in section 2. Oligonucleotide fusion temperatures are given by TmOC. Hybridization types are given ac- 
cording to [21]: type 1 (back to wt codon), type II (second mutation included in the probed region), type III (second mutation at a distant Site from 
the probed region). Sequences of revertants were performed as described in [13,1§,24]. Numbers in brackets represent he number of independent 
revertants sequenced having the same suppressor. Mutated a.mino acids are bold 
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threonine whereas the original mutation remained un- (not shown). Genetic analysis by ‘petite’ deletion mapp- 
changed [22]. ing of these type XII revertants is in progress. 
From this thermo-sensitive strain, about 80 spon- At the level of position 133, serine, phenylalanine, 
taneous independent revertants obtained at non-per- asparagine, aspartic acid and cysteine restored a good 
missive temperature (37°C) were analysed by a efficiency of growth on glycerol ranging from 50% to 
temperature-sensitive oligonucleotide hybridization nearly all of the wild type growth rate (see Table II), 
technique [21]. The original mutated site (residue 133) whereas histidine allowed only 5% of growth on 
and its upstream and downstream sequences were prob- glycerol. For the two revertants with a third mutation, 
ed with an oligonucleotide which is complementary to the efficiency of growth on glycerol was 11 o/o relative to 
the wild type mit DNA. Similarly as in [21], three the wild type (Table II). 
classes of revertants were found (see Table I). Among Revertants which have a gdod efficiency of growth 
$0 revertants which were analysed by hybridization, we on glycerol have been tested for their ability to grow in 
have found 14 (lgolo) type I (back to the wild type the presence of increasing concentrations of myx- 
codon), 35 (45Vo) type II (second site mutation included othiazol (in vivo myxothiazol tolerance test) (Table II), 
in the probed region} and 29 (37%) type III (second site The presence of an asparagine or an aspartic acid in 
mutation at a distant site from the probed region) rever- position 133 leads respectively to a 5-fold and an &fold 
tants. RNA sequences of the probed region (which relative increase in resistance comparatively to the wild 
overlap Ci33- > Y) of 33 revertants have been perform- type whereas trains with other suppressors at this posi- 
ed. Results of the sequencing gels are presented in Table tion, i.e. serine, phenylalanine and cysteine, are ap- 
I. In 24 revertants, two kinds of compensatory muta- parently myxothiazol-sensitive. 
tions were found: (i) on position 133, all amino acids 
which can be derived by mononucleotide substitution 
from the tyrosine codon (TAT) occurred: serine (TCT), 
phenylalanine (TTT), asparagine (AAT), aspartic acid 4. DISCUSSION 
(GAT), histidine (CAT) and cysteine (TGT, wild type Herein we describe the isolation and the molecular 
codon) whereas the second mutation of JDG3012/119, analysis of a new set of cytochrome b mutants. These 
a threonine instead of alanine 126, remained un- mutants affect a highly conserved region of the protein 
changed; (ii) acquisition of a third mutation at the level which is likely to be critical for the electron transfer, the 
of codon 135 where a valne is replaced by an isoleucine assembly of the bci complex and the binding of center 
or at the level of codon 130 where a leucine is replaced 
by a methionine (type III revertant). 
Moreover, in nine type III revertants, the presence of 
the two original mutations of JDG3012/11’7 (AIW >T 
and CW->Y) was confirmed, whereas the presence of 
a suppressor mutation was not found in the sequenced 
region of the mRNA (between positions 120 and 137) 
P side 
Table I1 
Relative growth rate and level of in vivo myxothiazol tolerance of 
revertants 
Strains Growth rate In vivo myxothia- 
(S of wt) 201 tolerance 
KM91 (wt) 100 0.1 
JDCi3012/117 (Yw T~za) 2 nd 
RS C&33, T~ze) 62 0.1 
R3 @133, I-126) 50 0.1 
R18 (Nr33, T126) 71 0.5 
R23 (D133, T126) 56 0.8 
RllO (H133. Tlza) 5 nd 
Rll (Cur, Trze) 100 0.1 
R87 (1135, Y133, Tm) 11 nd 
R82 (Y133, M130, TIZS) 11 nd 
Growth on glyserol at WC is expressed as the ratio of the revertant’s 
growth rate relative to that of the wild type. In viva myxothiazol 
tolerance is expressed in fig of myothiazol per ml of N3 medium 
neccssa:y to complete!y impair the growth 
nd: not determined 
28 
mit - mlt - 
(F151->C) 
Fig. 1. Schematic representation of the end of helix C and the 
beginning of the loop c-d from the cytochrome b eight helices model 
[25]. Resistant mutants (underlined}. JvlYX’, MUC’, STI’ [15]. 
Deficient mutants: mit’l31, mit‘142 1171, mit-133 [7], mit’137 [20], 
mit’l51 [lS]. Thermo-sensitive mutant: JDCI3012/117 [22] (the first 
suppressor is squared). I -1. indicates the positions of the 
ccrresponding exon limits of the split cytochrome b gene. B, 
represents the positive side of the membrane. 
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o inhibitors. Indeed, as illustrated in Fig. 1, in the cur- 50% of growth relatively to the wild type, Third, the 
rent eight helices model [25], the end of helix C and the combination of threoninc 126 with a histidine at posi- 
beginning of the loop c-d form a region where it has tidn 133 ‘is obtained for the first time and is compatible 
been assign.ed 4 center o inhibitor-resistant mutants and for a weak (5%) growth. This confirms that I-Ii33 is 
6 respiratory-deficient mutants, among which two have deleterious for the function, as proposed in 1211 because 
an impaired bcl complex assembly (see legend of it was the only change that was not found. Thus, at 
Fig. 1). position 133, even if small residues (independently of
Eight new local cytochrome bstructures were obtain- their hydrophobic or polar character) are more 
ed from the thermo-sensitive mutant JDG30121117 tolerated (60 to about 100% of growth on respiratory 
which carries two nucleotide changes at codons 133 and substrate) than a large residue like phenylalanine 
126 (Fig. 2A). From these results, some conclusions can (50010), it seems that the inability to grow on respiratory 
be drawn. First, a true back mutation at position 133 substrate is specifically due to the presence of tyrosine 
restoring the wild type cysteine (Fig. 2B) isolates the or histidine at position 133. It is thought that the 
suppressor mutation &26’> T and is found to be Com- neighbour invariant yrosine 132 is involved in the ox- 
.patible with a wild type growth (Table II). Second, idoreduction reaction at center o [21], so Yis~ and M133, 
pseudo-wild type mutations leading to the replacement modifying the local topology of the ubiquinol oxidation 
of tyrosine 133 by S, F, N and 119 (Fig. 2B) are the same site, could induce the quinol to react with wrong part- 
changes as those previously described as suppressors of nars. 
the original deficient G3012. mutation (C133->Y) 1211, Two revertants carrying a third site mutation which 
except hat in our case Ti26 remains present instead of compensate the inability to grow on respiratory 
the wild type alanine. This suggests that there is no an- substrate of the thermosensitive mutant JDG3012/117 
tagonism between these four suppressors and the muta- were also analysed. Helical wheel representations of the 
tion Ti26 located about two helical turns below the posi- mutated regions are shown in Fig. 2C and D. Although 
tion 133 (Fig. 2ls). This also underlines the specificity the relative growth rates of these two revertants are 
of the tyrosine, and more specifically of its hydroxyl identical (1 Io70), the nature of the suppressors and their 
group, in the loss of the capacity to grow on respiratory locations are very different. Indeed, the suppressor 
substrates (at least for about 50%). Indeed, the replace- Lijo->M is located on the same side of helix C as that 
ment of tyrosine 133 by a phenylalanine, both of amino of the previous mutations Y 133 and Tt26 (in close spatial 
acids having approximately the same volume, allows vicinity), whereas the suppressor V135-31 is located on 
the opposite side of helix C, one-half,turn after YIJJ. 
This suggests that these compensatory mutations prob- 
ably modify the local a-helix structure of the end of 
helix C, allowing a partial recovery of function even 
~~~ ia;- :: 
Am&g revertants exhibiting a good growth on’ 
respiratory substrate, i.e. S, F, N, D or CM (coupled 
with Ti26), Only reVertantS R18 (NM, TKX,) and B23 
133 Ti26) (Cf. Table I) were found t0 be resistant 
toward myxothiazol. Position 133 is surrounded by 
several positions for which resistance mutations toward 
myxothiazol were found, i.e. residue 129 in yeast 1151. 
Rhodobacter cagsulatus [ 1 I] and Chlmydomonas 
T D: l-is C reinhardhii [9] mutants, residue 137 in yeast [IS] and in 
D Rhodobacter capsulatus [ll] mutants, residue 143 in a 
;a i-I> 
A 
ITG 
I 
mouse mutant [121 and in the natural resistant Pamcen- 
I 
135124 131 F 135124 131 trotus lividus [26]. These residues are thought to form 
120 T 128 120 T 
127 121 127 a part of the myxothiazol binding niche [l 1,12,15]. This 
134 c y 132 134 C 
C c 
does not mean that position 133 is directly involved in 
123 L I 125 123 L 
130 
the binding of myxothiazol, but that the introduction of 
18 !3Q 
119 M[ V 129 119 I, charge a (D) or a polar character (N) and/or a better 122133 126 
I F I 
capacity in hydrogen bonding is likely to modify the 
1 YT myxothiazoi cytochrome P, interacting zone. 
We have selected and analysed a new generation of 
Fig. 2. Helical wheel representations of helix C of the wild type, the 
cytochrome bmutants affecting a region of the protein 
mutant and its eight revertants. (A) wild type and mutant @old) which is likely involved at center o of the proton-motive 
representation, (B) suppressors affecting position 133. (C) suppressor bcl complex and so is critical for the function. Further 
affecting position 130, (D) subpressore affecting position 135. biochemical studies are underway to deepen our 
,, 29 
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knowledge on the quinol oxidation site and the binding 
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